Home › Companies › Niagen Bioscience, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Niagen Bioscience, Inc.’s Form 8-K, filed June 29, 2026 (Item 5.07 on EDGAR). Page generated October 25, 2026.
Meeting of June 24, 2026: 10 items on Niagen Bioscience, Inc.’s Form 8-K, filed June 29, 2026: 8 elected · 2 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025 2025-2026
Explore Niagen Bioscience, Inc. in the interactive database Compare manager voting policies
These tallies are Niagen Bioscience, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 29, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Frank L. Jaksch, Jr. | 44,531,507 | -- | -- | 759,870 | 13,274,979 | 98% | Elected | — |
| Elect Director: Robert Fried | 44,822,825 | -- | -- | 468,552 | 13,274,979 | 99% | Elected | — |
| Elect Director: Steven Rubin | 28,495,147 | -- | -- | 16,796,230 | 13,274,979 | 63% | Elected | — |
| Elect Director: Wendy Yu | 44,520,972 | -- | -- | 770,405 | 13,274,979 | 98% | Elected | — |
| Elect Director: Gary Ng | 44,446,052 | -- | -- | 845,325 | 13,274,979 | 98% | Elected | — |
| Elect Director: Kristin Patrick | 43,608,014 | -- | -- | 1,683,363 | 13,274,979 | 96% | Elected | — |
| Elect Director: Ann Cohen | 44,360,218 | -- | -- | 931,159 | 13,274,979 | 98% | Elected | — |
| Elect Director: Hamed Shahbazi | 30,544,086 | -- | -- | 14,747,291 | 13,274,979 | 67% | Elected | — |
| 2. Ratification of the appointment of Crowe LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 | 56,152,066 | 2,256,090 | 158,200 | -- | -- | 96% | Not verified | — |
| 3. Approval, on an advisory basis, of the compensation paid to the Company's named executive officers | 43,188,958 | 1,930,441 | 171,978 | -- | 13,274,979 | 96% | Not verified | — |
Source: Niagen Bioscience, Inc., Form 8-K, filed with the SEC on June 29, 2026 — read the filing on EDGAR.
Each item below shows how the 153 asset managers that disclosed a Niagen Bioscience, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Ann Cohen
Niagen Bioscience, Inc.’s own tally for this item (“Elect Director: Ann Cohen”): 44,360,218 for, 931,159 withheld, per its Form 8-K filed June 29, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until his or her successor is elected, or, if sooner, until such director's death, resignation or removal.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 8,367,629 for, 3,872 withheld, 8 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,390,783 | 0 | 8 | 3,872 | For |
| Fidelity | 1,086,494 | 0 | 0 | 0 | For |
| BlackRock | 927,565 | 0 | 0 | 0 | For |
| Charles Schwab | 446,466 | 0 | 0 | 0 | For |
| Victory Capital | 324,790 | 0 | 0 | 0 | For |
| Dimensional | 273,512 | 0 | 0 | 0 | For |
| Gabelli | 250,870 | 0 | 0 | 0 | For |
| SEI | 203,824 | 0 | 0 | 0 | For |
| AllianceBernstein | 170,962 | 0 | 0 | 0 | For |
| Goldman Sachs | 144,310 | 0 | 0 | 0 | For |
| Equitable | 123,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 120,409 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 117,553 | 0 | 0 | 0 | For |
| TIAA | 111,122 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 88,560 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 73,746 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 60,000 | 0 | 0 | 0 | For |
| Nationwide | 44,018 | 0 | 0 | 0 | For |
| Lincoln Financial | 42,772 | 0 | 0 | 0 | For |
| WisdomTree | 35,746 | 0 | 0 | 0 | For |
| JPMorgan | 35,420 | 0 | 0 | 0 | For |
| American Century | 35,044 | 0 | 0 | 0 | For |
| AQR | 28,345 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 26,659 | 0 | 0 | 0 | For |
| Global X | 23,310 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Frank Jaksch, Jr.
Niagen Bioscience, Inc.’s own tally for this item (“Elect Director: Frank L. Jaksch, Jr.”): 44,531,507 for, 759,870 withheld, per its Form 8-K filed June 29, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until his or her successor is elected, or, if sooner, until such director's death, resignation or removal.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 8,234,338 for, 137,164 withheld, 7 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,382,964 | 0 | 7 | 11,692 | For |
| Fidelity | 1,086,494 | 0 | 0 | 0 | For |
| BlackRock | 927,565 | 0 | 0 | 0 | For |
| Charles Schwab | 446,466 | 0 | 0 | 0 | For |
| Victory Capital | 324,790 | 0 | 0 | 0 | For |
| Dimensional | 273,512 | 0 | 0 | 0 | For |
| Gabelli | 250,870 | 0 | 0 | 0 | For |
| SEI | 203,824 | 0 | 0 | 0 | For |
| AllianceBernstein | 170,962 | 0 | 0 | 0 | For |
| Goldman Sachs | 144,310 | 0 | 0 | 0 | For |
| Equitable | 123,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 0 | 0 | 0 | 120,409 | Withhold |
| FORUM FUNDS II | 117,553 | 0 | 0 | 0 | For |
| TIAA | 111,122 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 88,560 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 73,746 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 60,000 | 0 | 0 | 0 | For |
| Nationwide | 44,018 | 0 | 0 | 0 | For |
| Lincoln Financial | 42,772 | 0 | 0 | 0 | For |
| WisdomTree | 35,746 | 0 | 0 | 0 | For |
| JPMorgan | 35,420 | 0 | 0 | 0 | For |
| American Century | 35,044 | 0 | 0 | 0 | For |
| AQR | 28,345 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 26,659 | 0 | 0 | 0 | For |
| Global X | 23,310 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Gary Ng
Niagen Bioscience, Inc.’s own tally for this item (“Elect Director: Gary Ng”): 44,446,052 for, 845,325 withheld, per its Form 8-K filed June 29, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until his or her successor is elected, or, if sooner, until such director's death, resignation or removal.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 8,371,501 for, 8 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,394,655 | 0 | 8 | 0 | For |
| Fidelity | 1,086,494 | 0 | 0 | 0 | For |
| BlackRock | 927,565 | 0 | 0 | 0 | For |
| Charles Schwab | 446,466 | 0 | 0 | 0 | For |
| Victory Capital | 324,790 | 0 | 0 | 0 | For |
| Dimensional | 273,512 | 0 | 0 | 0 | For |
| Gabelli | 250,870 | 0 | 0 | 0 | For |
| SEI | 203,824 | 0 | 0 | 0 | For |
| AllianceBernstein | 170,962 | 0 | 0 | 0 | For |
| Goldman Sachs | 144,310 | 0 | 0 | 0 | For |
| Equitable | 123,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 120,409 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 117,553 | 0 | 0 | 0 | For |
| TIAA | 111,122 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 88,560 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 73,746 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 60,000 | 0 | 0 | 0 | For |
| Nationwide | 44,018 | 0 | 0 | 0 | For |
| Lincoln Financial | 42,772 | 0 | 0 | 0 | For |
| WisdomTree | 35,746 | 0 | 0 | 0 | For |
| JPMorgan | 35,420 | 0 | 0 | 0 | For |
| American Century | 35,044 | 0 | 0 | 0 | For |
| AQR | 28,345 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 26,659 | 0 | 0 | 0 | For |
| Global X | 23,310 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Combines 2 wordings of this item as funds reported it.
67% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Hamed Shahbazi
Niagen Bioscience, Inc.’s own tally for this item (“Elect Director: Hamed Shahbazi”): 30,544,086 for, 14,747,291 withheld, per its Form 8-K filed June 29, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until his or her successor is elected, or, if sooner, until such director's death, resignation or removal.”
Support: 67% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 2,036,471 for, 6,334,890 withheld, 149 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,232,352 | 0 | 149 | 2,162,163 | Mixed |
| Fidelity | 342 | 0 | 0 | 1,086,152 | Withhold |
| BlackRock | 0 | 0 | 0 | 927,565 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 446,466 | Withhold |
| Victory Capital | 0 | 0 | 0 | 324,790 | Withhold |
| Dimensional | 0 | 0 | 0 | 273,512 | Withhold |
| Gabelli | 250,870 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 203,824 | Withhold |
| AllianceBernstein | 0 | 0 | 0 | 170,962 | Withhold |
| Goldman Sachs | 144,310 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 0 | 123,405 | Withhold |
| Amplify ETF Trust | 120,409 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 117,553 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 111,122 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 88,560 | Withhold |
| Principal Exchange-Traded Funds | 0 | 0 | 0 | 73,746 | Withhold |
| TETON WESTWOOD FUNDS | 60,000 | 0 | 0 | 0 | For |
| Nationwide | 5,628 | 0 | 0 | 38,390 | Mixed |
| Lincoln Financial | 37,200 | 0 | 0 | 5,572 | Mixed |
| WisdomTree | 0 | 0 | 0 | 35,746 | Withhold |
| JPMorgan | 35,420 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 35,044 | Withhold |
| AQR | 0 | 0 | 0 | 28,345 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 26,659 | Withhold |
| Global X | 0 | 0 | 0 | 23,310 | Withhold |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Combines 2 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Kristin Patrick
Niagen Bioscience, Inc.’s own tally for this item (“Elect Director: Kristin Patrick”): 43,608,014 for, 1,683,363 withheld, per its Form 8-K filed June 29, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until his or her successor is elected, or, if sooner, until such director's death, resignation or removal.”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 8,324,459 for, 47,032 withheld, 18 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,394,645 | 0 | 18 | 0 | For |
| Fidelity | 1,086,494 | 0 | 0 | 0 | For |
| BlackRock | 927,565 | 0 | 0 | 0 | For |
| Charles Schwab | 446,466 | 0 | 0 | 0 | For |
| Victory Capital | 324,790 | 0 | 0 | 0 | For |
| Dimensional | 273,512 | 0 | 0 | 0 | For |
| Gabelli | 250,870 | 0 | 0 | 0 | For |
| SEI | 203,824 | 0 | 0 | 0 | For |
| AllianceBernstein | 170,962 | 0 | 0 | 0 | For |
| Goldman Sachs | 144,310 | 0 | 0 | 0 | For |
| Equitable | 123,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 120,409 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 117,553 | 0 | 0 | 0 | For |
| TIAA | 111,122 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 88,560 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 73,746 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 60,000 | 0 | 0 | 0 | For |
| Nationwide | 44,018 | 0 | 0 | 0 | For |
| Lincoln Financial | 5,572 | 0 | 0 | 37,200 | Mixed |
| WisdomTree | 35,746 | 0 | 0 | 0 | For |
| JPMorgan | 35,420 | 0 | 0 | 0 | For |
| American Century | 35,044 | 0 | 0 | 0 | For |
| AQR | 28,345 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 26,659 | 0 | 0 | 0 | For |
| Global X | 23,310 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Robert Fried
Niagen Bioscience, Inc.’s own tally for this item (“Elect Director: Robert Fried”): 44,822,825 for, 468,552 withheld, per its Form 8-K filed June 29, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until his or her successor is elected, or, if sooner, until such director's death, resignation or removal.”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 8,371,504 for, 5 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,394,658 | 0 | 5 | 0 | For |
| Fidelity | 1,086,494 | 0 | 0 | 0 | For |
| BlackRock | 927,565 | 0 | 0 | 0 | For |
| Charles Schwab | 446,466 | 0 | 0 | 0 | For |
| Victory Capital | 324,790 | 0 | 0 | 0 | For |
| Dimensional | 273,512 | 0 | 0 | 0 | For |
| Gabelli | 250,870 | 0 | 0 | 0 | For |
| SEI | 203,824 | 0 | 0 | 0 | For |
| AllianceBernstein | 170,962 | 0 | 0 | 0 | For |
| Goldman Sachs | 144,310 | 0 | 0 | 0 | For |
| Equitable | 123,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 120,409 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 117,553 | 0 | 0 | 0 | For |
| TIAA | 111,122 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 88,560 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 73,746 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 60,000 | 0 | 0 | 0 | For |
| Nationwide | 44,018 | 0 | 0 | 0 | For |
| Lincoln Financial | 42,772 | 0 | 0 | 0 | For |
| WisdomTree | 35,746 | 0 | 0 | 0 | For |
| JPMorgan | 35,420 | 0 | 0 | 0 | For |
| American Century | 35,044 | 0 | 0 | 0 | For |
| AQR | 28,345 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 26,659 | 0 | 0 | 0 | For |
| Global X | 23,310 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Combines 3 wordings of this item as funds reported it.
63% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Steven Rubin
Niagen Bioscience, Inc.’s own tally for this item (“Elect Director: Steven Rubin”): 28,495,147 for, 16,796,230 withheld, per its Form 8-K filed June 29, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until his or her successor is elected, or, if sooner, until such director's death, resignation or removal.”
Support: 63% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 791,640 for, 7,579,701 withheld, 168 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,594 | 0 | 168 | 3,377,901 | Withhold |
| Fidelity | 0 | 0 | 0 | 1,086,494 | Withhold |
| BlackRock | 0 | 0 | 0 | 927,565 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 446,466 | Withhold |
| Victory Capital | 0 | 0 | 0 | 324,790 | Withhold |
| Dimensional | 0 | 0 | 0 | 273,512 | Withhold |
| Gabelli | 250,870 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 203,824 | Withhold |
| AllianceBernstein | 0 | 0 | 0 | 170,962 | Withhold |
| Goldman Sachs | 144,310 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 0 | 123,405 | Withhold |
| Amplify ETF Trust | 120,409 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 117,553 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 111,122 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 88,560 | Withhold |
| Principal Exchange-Traded Funds | 0 | 0 | 0 | 73,746 | Withhold |
| TETON WESTWOOD FUNDS | 60,000 | 0 | 0 | 0 | For |
| Nationwide | 5,628 | 0 | 0 | 38,390 | Mixed |
| Lincoln Financial | 37,200 | 0 | 0 | 5,572 | Mixed |
| WisdomTree | 0 | 0 | 0 | 35,746 | Withhold |
| JPMorgan | 0 | 0 | 0 | 35,420 | Withhold |
| American Century | 0 | 0 | 0 | 35,044 | Withhold |
| AQR | 0 | 0 | 0 | 28,345 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 26,659 | Withhold |
| Global X | 0 | 0 | 0 | 23,310 | Withhold |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Wendy Yu
Niagen Bioscience, Inc.’s own tally for this item (“Elect Director: Wendy Yu”): 44,520,972 for, 770,405 withheld, per its Form 8-K filed June 29, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until his or her successor is elected, or, if sooner, until such director's death, resignation or removal.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 8,366,704 for, 4,797 withheld, 8 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,394,655 | 0 | 8 | 0 | For |
| Fidelity | 1,086,494 | 0 | 0 | 0 | For |
| BlackRock | 927,565 | 0 | 0 | 0 | For |
| Charles Schwab | 446,466 | 0 | 0 | 0 | For |
| Victory Capital | 324,790 | 0 | 0 | 0 | For |
| Dimensional | 273,512 | 0 | 0 | 0 | For |
| Gabelli | 250,870 | 0 | 0 | 0 | For |
| SEI | 203,824 | 0 | 0 | 0 | For |
| AllianceBernstein | 170,962 | 0 | 0 | 0 | For |
| Goldman Sachs | 144,310 | 0 | 0 | 0 | For |
| Equitable | 123,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 120,409 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 117,553 | 0 | 0 | 0 | For |
| TIAA | 111,122 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 88,560 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 73,746 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 60,000 | 0 | 0 | 0 | For |
| Nationwide | 44,018 | 0 | 0 | 0 | For |
| Lincoln Financial | 42,772 | 0 | 0 | 0 | For |
| WisdomTree | 35,746 | 0 | 0 | 0 | For |
| JPMorgan | 35,420 | 0 | 0 | 0 | For |
| American Century | 35,044 | 0 | 0 | 0 | For |
| AQR | 28,345 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 26,659 | 0 | 0 | 0 | For |
| Global X | 23,310 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Combines 6 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: A nonbinding advisory vote of the Company's stockholders, as recommended by the Compensation Committee and approved by the Board, on the compensation of the Company's named executive officers disclosed in the Proxy Solicitation Materials
Niagen Bioscience, Inc.’s own tally for this item (“3. Approval, on an advisory basis, of the compensation paid to the Company's named executive officers”): 43,188,958 for, 1,930,441 against, per its Form 8-K filed June 29, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,394,645 | 16 | 2 | 0 | For |
| Fidelity | 1,086,494 | 0 | 0 | 0 | For |
| BlackRock | 927,565 | 0 | 0 | 0 | For |
| Charles Schwab | 446,466 | 0 | 0 | 0 | For |
| Victory Capital | 324,790 | 0 | 0 | 0 | For |
| Dimensional | 0 | 273,512 | 0 | 0 | Against |
| Gabelli | 250,870 | 0 | 0 | 0 | For |
| SEI | 203,824 | 0 | 0 | 0 | For |
| AllianceBernstein | 170,962 | 0 | 0 | 0 | For |
| Goldman Sachs | 144,310 | 0 | 0 | 0 | For |
| Equitable | 123,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 120,409 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 117,553 | 0 | 0 | 0 | For |
| TIAA | 111,122 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 88,560 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 73,746 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 60,000 | 0 | 0 | 0 | For |
| Nationwide | 20,218 | 23,800 | 0 | 0 | Mixed |
| Lincoln Financial | 37,200 | 5,572 | 0 | 0 | Mixed |
| WisdomTree | 35,746 | 0 | 0 | 0 | For |
| JPMorgan | 35,420 | 0 | 0 | 0 | For |
| American Century | 0 | 35,044 | 0 | 0 | Against |
| AQR | 28,345 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 26,659 | 0 | 0 | 0 | For |
| Global X | 23,310 | 0 | 0 | 0 | For |
Fund voting reports, all 51 managers: 8,003,301 for, 368,206 against, 2 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Tieton Capital Management, LLC | 1,456,000 | 0 | 0 | 0 | For |
| BlackRock | 1,347,354 | 22,889 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,260,192 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 863,155 | 9,413 | 0 | 0 | For |
| State Street | 841,048 | 1,946 | 0 | 0 | For |
| AQR | 452,904 | 0 | 0 | 0 | For |
| Charles Schwab | 447,408 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 434,039 | 0 | 0 | 0 | For |
| Victory Capital | 427,313 | 0 | 0 | 0 | For |
| Vanguard | 397,646 | 0 | 0 | 0 | For |
| Maryland State Retirement & Pension System | 394,990 | 0 | 0 | 0 | For |
| Goldman Sachs | 238,258 | 0 | 0 | 0 | For |
| Northern Trust | 211,930 | 0 | 0 | 0 | For |
| SEI | 203,970 | 0 | 0 | 0 | For |
| AllianceBernstein | 203,512 | 0 | 0 | 0 | For |
| T. Rowe Price | 188,864 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 179,771 | 0 | 0 | 0 | For |
| DE Shaw | 158,816 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 148,167 | 0 | 0 | 0 | For |
| RBC Dominion Securities Inc. | 124,890 | 0 | 0 | 0 | For |
| Nuveen | 123,270 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 112,105 | 0 | 0 | 0 | For |
| Citadel | 103,885 | 0 | 0 | 0 | For |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 100,555 | 0 | 0 | 0 | For |
| ClariVest Asset Management LLC | 96,612 | 0 | 0 | 0 | For |
Institutional-manager reports, all 119 managers: 11,350,114 for, 255,940 against. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: RATIFICATION OF THE AUDIT COMMITTEE'S SELECTION OF CROWE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026
Niagen Bioscience, Inc.’s own tally for this item (“2. Ratification of the appointment of Crowe LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 56,152,066 for, 2,256,090 against, per its Form 8-K filed June 29, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 8,270,724 for, 100,783 against, 2 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,394,643 | 18 | 2 | 0 | For |
| Fidelity | 1,086,494 | 0 | 0 | 0 | For |
| BlackRock | 927,565 | 0 | 0 | 0 | For |
| Charles Schwab | 446,466 | 0 | 0 | 0 | For |
| Victory Capital | 324,790 | 0 | 0 | 0 | For |
| Dimensional | 273,512 | 0 | 0 | 0 | For |
| Gabelli | 250,870 | 0 | 0 | 0 | For |
| SEI | 203,824 | 0 | 0 | 0 | For |
| AllianceBernstein | 170,962 | 0 | 0 | 0 | For |
| Goldman Sachs | 144,310 | 0 | 0 | 0 | For |
| Equitable | 123,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 120,409 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 16,788 | 100,765 | 0 | 0 | Mixed |
| TIAA | 111,122 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 88,560 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 73,746 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 60,000 | 0 | 0 | 0 | For |
| Nationwide | 44,018 | 0 | 0 | 0 | For |
| Lincoln Financial | 42,772 | 0 | 0 | 0 | For |
| WisdomTree | 35,746 | 0 | 0 | 0 | For |
| JPMorgan | 35,420 | 0 | 0 | 0 | For |
| American Century | 35,044 | 0 | 0 | 0 | For |
| AQR | 28,345 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 26,659 | 0 | 0 | 0 | For |
| Global X | 23,310 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 79,644,327 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.26% |
| 2 | Fidelity | 1.36% |
| 3 | BlackRock | 1.16% |
| 4 | Charles Schwab | 0.56% |
| 5 | Victory Capital | 0.41% |
| 6 | Dimensional | 0.34% |
| 7 | Gabelli | 0.31% |
| 8 | SEI | 0.26% |
| 9 | AllianceBernstein | 0.21% |
| 10 | Goldman Sachs | 0.18% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Tieton Capital Management, LLC | 1.83% |
| 2 | BlackRock | 1.72% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 1.58% |
| 4 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.10% |
| 5 | State Street | 1.06% |
| 6 | AQR | 0.57% |
| 7 | Charles Schwab | 0.56% |
| 8 | Connor, Clark & Lunn Investment Management Ltd. | 0.54% |
| 9 | Victory Capital | 0.54% |
| 10 | Vanguard | 0.50% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Chau Hoi Shuen Solina Holly | 24.23% | DEF14A |
| Robert Fried | 5.86% | DEF14A |
| BlackRock | 4.86% | 13F |
| Vanguard Group | 4.13% | 13F |
| Frank L. Jaksch, Jr. | 3.49% | DEF14A |
| Geode Capital | 1.69% | 13F |
| Renaissance Technologies | 1.67% | 13F |
| Goldman Sachs | 1.57% | 13F |
| State Street | 1.36% | 13F |
| Dimensional Fund Advisors | 1.34% | 13F |
Percentages above are of 79,644,327 shares outstanding, as reported by Niagen Bioscience, Inc. on its Form 10-Q dated May 4, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Niagen Bioscience, Inc.’s 10-Q dated May 4, 2026. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.
At Niagen Bioscience, Inc.'s shareholder meeting held June 24, 2026, in the 2025-2026 proxy season, 153 asset managers reported how they voted on 10 ballot items in their SEC Form N-PX filings, covering 1,667 separate fund positions. On the most widely held item on that ballot — A nonbinding advisory vote of the Company's stockholders, as recommended by the Compensation… — FOR was 96% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Niagen Bioscience, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 29, 2026.
Niagen Bioscience, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.